IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RXI Pharmaceuticals Corp New

CUSIP: 74979C903 | 1 institutional holders

Quarters

Q4 2014Q3 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile